1. 8 key clinical trials to watch for the rest of 2021 — Roche Alzheimer's antibody lowers biomarkers in inherited form of disease -- GSK set to ask investors to keep the faith See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

Compliance

Discussion in 'Novartis' started by anonymous, Apr 13, 2021 at 9:34 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Hospital rep partnering with a rep from another company...working together. This is against compliance. Sharing appointments and business plans. Might have to be whistle blower.
     

  2. anonymous

    anonymous Guest

    I think it is pretty clear that we are in a divisional race to see who will be responsible for our next CIA.. With Kesimpta's launch going so poor, and some of the behavior in Neuroscience currently, my bet is NS.
     
  3. anonymous

    anonymous Guest

    Had a nurse tell me 2 reps saw her on the floor both with different companies and products. Seems like one of the reps spouse works as Novartis and her spouse works for a different company! Her rep helping her husband.
     
  4. anonymous

    anonymous Guest

    Oh who cares... job is a joke anyway. Do the products compete? That would be one thing. If not, eh. Prob more efficient for the staff to see them both same time and get it over with.
     
  5. anonymous

    anonymous Guest

    You obviously don’t work in MS or you would know that the launch is quite the opposite. The place to be—right now!
     
  6. anonymous

    anonymous Guest

    Ha. There will be and entire sales team let go before sales # are good enough for NS to be the place to be!
     
  7. anonymous

    anonymous Guest

    We are on a hiring freeze so the people jumping ship will only help the others who want to be here. We all never know when we will face adversity in this business. All you can do is control your performance. I’ve been here long enough to know that when you are in a good division/drug launch and things are going well you typically have a solid 3 years before any changes. Obviously, 2020 was an entire new hurdle we all had to overcome and still dealing with the challenges of COVID.
     
  8. anonymous

    anonymous Guest

    If that is true, you should report it internally. You have a responsibility to do so.
     
  9. anonymous

    anonymous Guest

    It may be against our compliance but it isn't against any law. The government would never force a fine or CIA type agreement.

    Talk about some petty ass shit.
     
  10. anonymous

    anonymous Guest


    You are right. They would however nail us for these NS sales specialist going off label, acting like they are MSLs. If the company cared about compliance and ethics there would be a serious house cleaning done in NS, and it would include TLLs promising HCPs future $$$ opportunities.
     
  11. anonymous

    anonymous Guest

    Collusion...price fixing...antitrust laws come to mind
    ...no wonder CIA agreements are so common
     
  12. anonymous

    anonymous Guest

    CIA agreements so common to Novartis are very rare at other pharma cos. What does that tell you about Novartis?
     
  13. anonymous

    anonymous Guest

    The 2020 CIA is the most comprehensive in the pharma industry. It's the template for other companies to follow inside and outside of pharma. This recent CIA happened to Novartis not another company. $678 million fine.

    So we thought that was the last case and Novartis would no longer be in the news for bad behavior. Last week a new issue in Italy which is going to trial. Last month a Chairman at Novartis made comments that were incorrect about the CIA. He is still employed. Would you bet that this bad behavior is over? When is the next issue brought to the public's attention?
     
  14. anonymous

    anonymous Guest


    You really don't know what you are talking about. Since the beginning of this century, CIA's have been commonplace among big pharma companies. All pharma companies do risk assessment to determine potential reward of a marketing practice vs potential penalties. Pharma isn't alone in doing this. Probably the most famous example of this is when FORD sold the Pinto. Ford realize a design defect that cause gas tank explosions from rear-end collisions would be less costly to pay lawsuit settlements than repair the defects. This decision eventually cost Lee Iocaca his job.
     
  15. anonymous

    anonymous Guest

    I'm thinking this post is probably coming from someone who acts in a way that will land NVS it's next CIA.
     
  16. anonymous

    anonymous Guest

    This mindset did not come from the sales force. It came from corporate adoption of the OZ principle. The OZ principle emphasizes out of the box thinking and accountability. Although accountability always seemed to roll downhill from the E-suite.